Literature DB >> 6854061

Bactericidal and opsonic activity of ascitic fluid from cirrhotic and noncirrhotic patients.

H E Akalin, Y Laleli, H Telatar.   

Abstract

Cirrhotic patients with ascites are highly susceptible to spontaneous bacterial peritonitis. Patients with ascites due to causes other than cirrhosis very seldom develop peritonitis. The antibacterial activity of these ascitic fluids is not known. The present study was undertaken to evaluate the bactericidal and opsonic activity in ascitic fluid from patients with and without cirrhosis and in normal (nonascitic) peritoneal fluid. Normal peritoneal fluids of 20 control subjects and ascitic fluids of 22 patients with noncirrhotic ascites all had normal bactericidal activity. The bactericidal activity of ascitic fluid was diminished in all 25 patients with cirrhosis (P less than 0.00005 by Fisher's exact test). Similar results were found when opsonic activity was evaluated. Complement and immunoglobulin concentrations in cirrhotic ascites were significantly lower than those in the other two groups. The present study demonstrates that noncirrhotic ascitic fluid has antibacterial activity similar to normal peritoneal fluid, whereas cirrhotic ascitic fluid has a marked reduction of both bactericidal and opsonic activities. These defects may explain the high incidence of peritonitis in cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854061     DOI: 10.1093/infdis/147.6.1011

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.

Authors:  D L Gordon; J L Rice; V M Avery
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

Review 2.  Problems of bacterial infection in patients with liver disease.

Authors:  R J Wyke
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

3.  Spontaneous peritonitis caused by Neisseria meningitidis serogroup B.

Authors:  F Bella Cueto; J Rey Abella; M A Morera Pomarede; E Espejo Arenas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

4.  Spontaneous peritonitis due to Brucella melitensis in a patient with cirrhosis.

Authors:  F Demirkan; H E Akalin; H Simşek; E Ozyilkan; H Telatar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

5.  Spontaneous bacterial peritonitis complicating malignancy-related ascites.

Authors:  D V Bac; S de Marie; M van Blankenstein
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

6.  Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis.

Authors:  Rubén Francés; José M González-Navajas; Pedro Zapater; Carlos Muñoz; Rocío Caño; Sonia Pascual; Dorkas Márquez; Francia Santana; Miguel Pérez-Mateo; José Such
Journal:  J Clin Immunol       Date:  2007-04-03       Impact factor: 8.317

7.  Liver cirrhosis with synchronous gas gangrene and spontaneous bacterial peritonitis due to E. coli.

Authors:  K Murata; A Shimizu; K Takase; T Nakano; Y Tameda
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

Review 8.  Diagnostic and therapeutic challenges of intraabdominal infections.

Authors:  O D Rotstein; J L Meakins
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

9.  Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.

Authors:  Y Weinrauch; A Foreman; C Shu; K Zarember; O Levy; P Elsbach; J Weiss
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis.

Authors:  J M Llovet; R Bartolí; R Planas; E Cabré; M Jimenez; A Urban; I Ojanguren; J Arnal; M A Gassull
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.